Heart Recovery Center Launched at Miller School of Medicine
The Miller School of Medicine has launched the first-in-the-nation Heart Recovery Center, further underscoring its expertise in treating cardiovascular disease. This new focus on recovering heart muscle was on display last week as the Miller School hosted a regional hemodynamics course, complete with a live case presentation to more than 100 of the country’s leading interventional cardiologists.
Alan Heldman, M.D., interventional cardiologist and professor of medicine in the Cardiovascular Division, has been appointed director of the Heart Recovery Center at University of Miami Hospital, the first in the United States. Centers are being established by device maker Abiomed to enable research, treatment and clinical education around the practice of heart recovery in several different areas, including interventional cardiology, cardiac surgery, electrophysiology, heart failure, cardiac rehabilitation and stem cell therapy.
“Because of our clinicians’ and scientists’ expertise,” says Heldman, “we are able to deliver the most advanced approach to cardiac care in the nation, here at UHealth. One of the hallmarks of heart recovery is improvement in the measurements of blood flow – the hemodynamics. With heart recovery and better hemodynamics, patients with seriously damaged hearts may return to sustainable and improved quality of life at home.”
William O’Neill, M.D., executive dean for clinical affairs at the Miller School and also a renowned interventional cardiologist, says UHealth-University of Miami Health System has devoted “considerable focus to a wide range of techniques to improve hemodynamics in patients. We have a dedicated and experienced team using the latest devices toward that end, improving their quality of life.”
To demonstrate that expertise to a gathering of the nation’s leading interventional cardiologists meeting on Miami Beach, O’Neill was televised January 20 as he performed a complex catheterization procedure that would not have been possible without advanced hemodynamic support technology. The goal of the minimally invasive catheterization procedure was to restore blood flow to areas of the heart muscle to improve heart function and facilitate recovery.